脓毒症相关30天风险标准化再入院:全国 Medicare 样本分析
该横断面研究基于2008至2011年 Medicare 按服务收费数据库,纳入3315家医院共633407例脓毒症住院患者,计算医院层面的30天风险标准化再入院率。中位再入院率为28.7%(四分位距26.1-31.9),不同地区、教学状态、服务弱势患者比例及医院规模间存在差异。综合质量评分最高的医院再入院率反而最高(32.0% vs 27.5%),死亡率最高的医院再入院率较低(28.7% vs 30.7%)。作者认为可能存在风险标准化不足等多种解释,需进一步研究。
要点
- 脓毒症幸存者30天风险标准化再入院率中位数为28.7%(IQR 26.1-31.9),即约三分之一幸存者再入院。
- 教学医院再入院率高于非教学医院(31.1% vs 29.0%,p<0.001)。
- 服务弱势患者比例最高的医院再入院率高于最低者(30.6% vs 28.7%,p<0.001)。
- 综合质量评分最高的医院再入院率高于最低者(32.0% vs 27.5%,p<0.001)。
- 死亡率最高的医院再入院率低于死亡率最低者(28.7% vs 30.7%,p<0.001)。
适用人群与场景
- 2008至2011年 Medicare 按服务收费数据库中,采用 Angus 方法通过 ICD-9 编码识别的脓毒症住院患者。
- 分析对象为脓毒症幸存者出院后的30天再入院,覆盖3315家参与 Medicare 的急性期医院。
研究设计与关键结果
- 研究类型为横断面研究,样本为2008至2011年3315家医院的633407例脓毒症住院。
- 中位风险标准化30天再入院率为28.7%(IQR 26.1-31.9)。
- 地区差异:东北部30.4%、南部29.6%、中西部28.8%、西部27.7%(p<0.001)。
- 教学医院再入院率31.1% vs 非教学医院29.0%(p<0.001)。
- 服务弱势患者比例最高的医院30.6% vs 最低者28.7%(p<0.001)。
- 综合质量评分最高的医院再入院率32.0% vs 最低者27.5%(p<0.001)。
- 死亡率最高的医院再入院率28.7% vs 死亡率最低者30.7%(p<0.001)。
证据类型、等级与局限
- 证据类型:横断面研究。
- 局限:原文未报告局限性;作者在结论中提出可能存在风险标准化不足等多种解释,需进一步研究。
对床旁实践的改变
- 作者认为脓毒症幸存者再入院率高且医院间差异大,多种人口学和结构因素与差异相关。
- 作者认为院内高质量指标与更高再入院率相关,可能存在风险标准化不足等多种解释,需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine national readmission rates among sepsis survivors, variations in rates between hospitals, and determine whether measures of quality correlate with performance on sepsis readmissions.
DESIGN: Cross-sectional study of sepsis readmissions between 2008 and 2011 in the Medicare fee-for-service database.
SETTING: Acute care, Medicare participating hospitals from 2008 to 2011.
PATIENTS: Septic patients as identified by International Classification of Diseases, Ninth Revision codes using the Angus method.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We generated hospital-level, risk-standardized, 30-day readmission rates among survivors of sepsis and compared rates across region, ownership, teaching status, sepsis volume, hospital size, and proportion of underserved patients. We examined the relationship between risk-standardized readmission rates and hospital-level composite measures of quality and mortality. From 633,407 hospitalizations among 3,315 hospitals from 2008 to 2011, median risk-standardized readmission rates was 28.7% (interquartile range, 26.1-31.9). There were differences in risk-standardized readmission rates by region (Northeast, 30.4%; South, 29.6%; Midwest, 28.8%; and West, 27.7%; p < 0.001), teaching versus nonteaching status (31.1% vs 29.0%; p < 0.001), and hospitals serving the highest proportion of underserved patients (30.6% vs 28.7%; p < 0.001). The best performing hospitals on a composite quality measure had highest risk-standardized readmission rates compared with the lowest (32.0% vs 27.5%; p < 0.001). Risk-standardized readmission rates was lower in the highest mortality hospitals compared with those in the lowest (28.7% vs 30.7%; p < 0.001).
CONCLUSIONS: One third of sepsis survivors were readmitted and wide variation exists between hospitals. Several demographic and structural factors are associated with this variation. Measures of higher quality in-hospital care were correlated with higher readmission rates. Several potential explanations are possible including poor risk standardization, more research is needed.
参考来源
- Norman BC, Cooke CR, Ely EW, et al. Sepsis-Associated 30-Day Risk-Standardized Readmissions: Analysis of a Nationwide Medicare Sample. Crit Care Med. 2017. PMID: 28471814. doi:10.1097/CCM.0000000000002476
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。